Editorial standards

Released: June 1, 2026 · Last reviewed: November 9, 2026

Sources

1. Sellers' own pages for prices and terms, with read dates.
2. FDA, CMS, Medicare.gov, the Federal Register and prescribing information for regulatory and clinical facts.
3. Peer-reviewed trials (STEP, SUSTAIN, SELECT) named by trial.
4. Tier-1 press only to point to a primary document.

Rules we follow

• No invented prices, reviews, ratings or quotes; if we could not re-read a page we say so and give the old date.
• Compounded semaglutide is described as not FDA-approved and not the same product as Wegovy or Ozempic.
• "Lowest" or "cheapest" is always scoped to the programs we track.
• Pages show the release date, the last content review and the last medical review.
• Corrections are logged publicly.

Ranking

See methodology v4.1. SemaglutideGLPOne.com is affiliate-supported and may earn a commission when readers enroll through links on this site. Compensation never changes our methodology, rankings or the prices we report.